Devices › Device, vascular, for promoting embolization
Device brand name · Device vascular for promoting embolization
Axium Prime Brpl 3d: medical device reports filed with FDA
902 reports name it, 2016–2026. Manufacturer given most often on reports: Micro Therapeutics Ev3. Product code KRD.
- 902
- device reports naming the brand
- 0% of all MAUDE reports · about 87 a year
- 135
- reports, 12 months to August 2026
- 126 in the 12 months before
- 91.5%
- classified as malfunction
- 74.9% across the product code
- 1%
- classified as death, as reported
- 9 reports · not verified by FDA
902 medical device reports received by FDA name the brand "Axium Prime Brpl 3d" (device vascular for promoting embolization); the manufacturer given most often on reports is Micro Therapeutics Ev3; received from February 2016 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
135 reports arrived in the 12 months to August 2026, close to the 126 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (91.5%), injury (7.5%) and death (1%); across all device, vascular, for promoting embolization reports (product code KRD) death is recorded in 1.6% and malfunction in 74.9%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are separation failure (36.6%), detachment of device or device component (31.5%) and physical resistance/sticking (28%). The patient problems coded most often are foreign body in patient, paresis and diplopia/double vision. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 14,553 reports carrying product code KRD. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Separation failure | 330 | 36.6% | 18.8% |
| Detachment of device or device componentpart of the device came off | 284 | 31.5% | 12.6% |
| Physical resistance/sticking | 253 | 28% | 9.3% |
| Stretched | 115 | 12.7% | 11.1% |
| Breakthe device broke | 97 | 10.8% | 6.3% |
| Material deformation | 93 | 10.3% | 3.5% |
| Unintended movement | 42 | 4.7% | 1.2% |
| Packaging problem | 31 | 3.4% | 0.9% |
| Migrationthe device moved from where it was placed | 28 | 3.1% | 3.4% |
| Detachment of device component | 24 | 2.7% | 3.8% |
| Difficult or delayed positioning | 14 | 1.6% | 0.8% |
| Therapy delivered to incorrect body area | 13 | 1.4% | 0.4% |
| Inadequacy of device shape and/or size | 7 | 0.8% | 0.6% |
| Migration or expulsion of device | 6 | 0.7% | 3% |
| Deformation due to compressive stress | 5 | 0.6% | 1.2% |
| Product quality problem | 5 | 0.6% | 0.3% |
| Activation, positioning or separation problem | 4 | 0.4% | 1.3% |
| Display or visual feedback problem | 4 | 0.4% | 0.1% |
| Incomplete or missing packaging | 4 | 0.4% | 0.1% |
| Premature separation | 2 | 0.2% | 6.7% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Foreign body in patientpart of a device left in the patient | 32 | 3.5% |
| Paresis | 10 | 1.1% |
| Diplopia/double vision | 9 | 1% |
| Fistula | 9 | 1% |
| Ptosis | 9 | 1% |
| Intracranial hemorrhage | 8 | 0.9% |
| Failure of implant | 6 | 0.7% |
| Ischemia | 6 | 0.7% |
| Paralysis | 6 | 0.7% |
| Obstruction/occlusion | 5 | 0.6% |
| Therapeutic response, decreased | 5 | 0.6% |
| Air embolism | 4 | 0.4% |
| Dysphasia | 4 | 0.4% |
| Nervous system injury | 4 | 0.4% |
| Reduced blood flow | 4 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Axium Prime Brpl 3d | Product code KRD | All MAUDE reports |
|---|---|---|---|
| Reports | 902 | 14,553 | 26,136,888 |
| Share of that pool | — | 6.2% | 0% |
| Classified as death, per 1,000 reports | 10 | 16 | 9 |
| Classified as injury | 7.5% | 22.9% | 36.2% |
| Classified as malfunction | 91.5% | 74.9% | 62.3% |
| Filed by the manufacturer | 100% | 97.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code KRD
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Concerto Nylon | 900 | 160 | 2.6% |
| Interlock? | 688 | 37 | 0% |
| Interlock-35 | 626 | 2 | 0.2% |
| Axium Prime Brpl Hlx | 616 | 106 | 1% |
| Interlock?-35 | 542 | 94 | 2.2% |
| Axium 3d | 429 | 48 | 1.6% |
| AZUR CX 35 Detachable | 388 | 58 | 0% |
| Axium Framing Coil | 286 | 57 | 0% |
| Azur CX Detachable | 278 | 38 | 0% |
| Concerto Pgla Hlx | 247 | 54 | 0.8% |
| Axium Helix | 231 | 24 | 3% |
| Retracta Detachable Embolization Coil | 228 | 20 | 0.9% |
| Microvascular Plug | 165 | 11 | 0.6% |
| Axium Prime Bare Pl 3d | 150 | 27 | 0% |
| Concerto | 843 | 199 | 2.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Axium Prime Brpl 3d reports
How many FDA reports name Axium Prime Brpl 3d?
902 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 135 in the latest 12 months.
What kinds of events are reported?
malfunction (91.5%), injury (7.5%) and death (1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
separation failure (36.6%), detachment of device or device component (31.5%), physical resistance/sticking (28%), stretched (12.7%) and break (10.8%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Axium Prime Brpl 3d was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.